Article Figures & Data
Figures
- Figure 1.
Percentage of adult survivors of childhood cancer with medical visits in a 2-year period by interval from cancer diagnosis to baseline questionnaire.
* Trend significant with P <.001 for general physical education, cancer-related medical visit, and cancer center medical visit by Cochran-Armitage trend test.
- Figure 2.
Percentage of adult survivors of 4 higher risk cancer groups with a cancer-related medical visit in a 2-year period by interval from cancer diagnosis to baseline questionnaire.
Note: Trend significant with P <.001 for bone tumor, central nervous system (CNS) tumor, Hodgkin’s disease, and leukemia survivors by Cochran-Armitage trend test.
Tables
- Table 1.
Percentage of Adult Survivors of Childhood Cancer Who Reported the Following Types of Outpatient Medical Care in a 2-Year Period: Sociodemographic Factors
Factor Number General Medical Contact (%) General Physical Examination (%) Cancer- Related Medical Visit (%) Cancer Center Medical Visit (%) <HS graduate = some high school, did not graduate; HS/some college = high school graduate or high school graduate with some college courses. Note: Percentages are based upon the total with available data for each variable. Age at interview 18–19 y 1,126 88.4 82.7 48.6 31.0 20–24 y 2,752 87.7 73.1 45.1 24.2 25–29 y 2,528 85.8 67.6 38.7 21.5 30–34 y 1,849 86.8 65.0 39.9 17.5 35–48 y 1,179 86.8 67.0 37.8 16.6 Sex Male 5,020 82.0 65.3 39.6 22.3 Female 4,414 93.6 75.8 44.5 21.9 Race/ethnicity White, non-Hispanic 7,886 87.7 70.2 41.8 21.5 Black, non-Hispanic 392 79.1 72.9 34.8 20.0 Hispanic 434 83.2 71.2 47.3 32.2 Others 273 82.6 69.0 45.1 24.7 Education <HS graduate 959 82.8 68.1 44.4 26.2 HS/some college 5,239 85.6 69.2 40.2 21.3 College graduate 2,723 90.5 72.2 43.7 22.7 Health insurance Yes 7,835 88.7 73.0 43.5 22.4 No 1,439 78.1 55.2 32.8 19.7 Household income <$20,000 1,870 83.7 64.9 41.5 20.0 ≥$20,000 6,403 88.5 72.3 41.9 22.3 - Table 2.
Percentage of Adult Survivors of Childhood Cancer Who Reported the Following Types of Outpatient Medical Care in a 2-Year Period: Cancer-Related Factors
Factor Number General Medical Contact % General Physical Examination % Cancer-Related Medical Visit % Cancer Center Medical Visit % Note: Percentages are based upon the total with available data for each variable. Age at diagnosis 0–4 y 2,426 86.0 72.4 36.4 18.2 5–9 y 2,336 86.2 71.6 41.1 23.3 10–14 y 2,540 87.2 68.4 43.5 23.6 15–21 y 2,132 88.6 69.0 46.9 23.2 Interval from cancer diagnosis 5–9 y 293 93.8 76.6 64.4 39.6 10–14 y 2,472 88.5 74.0 53.5 31.2 15–19 y 3,456 87.3 72.8 40.5 21.4 20–24 y 2,602 85.5 65.2 33.4 14.2 25–29 y 611 82.2 60.6 28.0 11.5 Cancer diagnosis Leukemia 2,846 85.0 72.4 36.3 22.4 Central nervous system tumor 1,166 88.6 66.3 52.9 14.8 Hodgkin’s disease 1,631 90.6 76.0 52.6 29.9 Non-Hodgkin’s lymphoma 865 84.2 68.3 36.9 21.6 Wilms’ tumor 630 88.2 68.8 33.7 18.0 Neuroblastoma 399 86.4 68.9 28.0 13.8 Sarcoma 894 75.0 67.8 39.9 19.6 Bone 1,003 88.4 65.4 43.8 24.9 Subjective health status Excellent 1,954 82.3 72.7 34.8 22.0 Very good 3,553 87.9 72.8 40.1 22.0 Good 2,834 88.6 68.7 45.1 22.4 Fair 844 87.9 63.7 51.8 21.6 Poor 146 89.7 51.1 62.1 24.4 Future health concerns Very concerned 2,787 88.9 73.5 48.0 23.9 Somewhat concerned 1,901 89.5 71.7 44.5 24.8 Concerned 2,298 87.1 70.0 40.4 21.7 Not very concerned 1,413 85.6 67.3 35.5 19.5 Not concerned at all 810 78.3 62.1 31.0 15.1 Cancer pain None 7,092 86.3 71.3 38.8 21.0 Small 976 90.0 69.9 49.9 25.0 Medium 608 89.4 67.3 54.2 26.6 A lot 232 88.7 67.3 59.3 27.9 Very bad 77 86.8 52.1 63.4 30.3 Cancer anxiety None 5,230 83.8 69.5 35.9 19.8 Small 2,513 91.8 72.7 47.3 23.6 Medium 808 91.7 71.7 55.5 27.2 A lot 300 90.9 73.1 59.3 30.4 Very many 73 90.4 61.4 48.5 31.8 - Table 3.
Multivariate Risk Factors for Absence of the Following Types of Outpatient Medical Care in a 2-Year Period in Adult Survivors of Childhood Cancer
Absence of General Medical Contact General Physical Examination Cancer-Related Medical Visit Cancer Center Medical Visit Variable OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR = odds ratio; CI = confidence interval; <HS graduate = some high school, did not graduate; HS/some college = high school graduate or high school graduate with some college courses. * High-risk treatment = treatment with any of the following: chest or mantle radiation, anthracycline ≥300 mg/m2, bleomycin, etoposide, or ifosfamide. Age at interview 18–19 y 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent 20–24 y 1.18 0.90–1.56 2.06 1.62–2.61 1.11 0.92–1.33 1.31 1.07–1.61 25–29 y 1.47 1.11–1.95 3.12 2.45–3.97 1.67 1.38–2.02 1.88 1.51–2.34 30–34 y 1.59 1.18–2.15 3.75 2.91–4.82 1.74 1.42–2.14 2.79 2.19–3.56 ≥35 y 1.71 1.23–2.37 3.64 2.78–4.76 2.29 1.83–2.87 3.43 2.61–4.51 Sex Female 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent Male 2.54 2.15–2.99 1.53 1.36–1.71 1.18 1.06–1.30 1.15 1.01–1.30 Ethnicity White, non-Hispanic 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent Minority 1.53 1.21–1.93 0.81 0.66–0.99 0.97 0.81–1.16 0.79 0.64–0.96 Education College graduate 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent HS/some college 1.48 1.22–1.79 1.21 1.06–1.38 1.16 1.03–1.31 1.25 1.08–1.44 <HS graduate 1.88 1.41–2.52 1.34 1.06–1.70 1.14 0.92–1.41 1.07 0.84–1.37 Health insurance Yes 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent No 2.14 1.78–2.57 2.19 1.87–2.56 1.64 1.40–1.92 1.41 1.16–1.70 Health status Good 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent Fair/poor 0.94 0.72–1.22 1.42 1.18–1.71 0.62 0.52–0.74 1.01 0.82–1.24 Concern for future health Concerned 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent Not concerned 1.44 1.21–1.71 1.38 1.21–1.58 1.51 1.33–1.71 1.53 1.31–1.79 High-risk treatment* No 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent Yes 0.73 0.62–0.86 0.72 0.64–0.81 0.59 0.52–0.65 0.45 0.39–0.51 - Table 4.
Percentage of Adult Survivors of Childhood Cancer Treated With Therapies Associated With Increased Risk for Late Effects Reporting an Absence of the Following Types of Outpatient Medical Care in a 2-Year Period, Compared With All Survivors
Absence of General Medical Contact General Physical Examination Cancer-Related Medical Visit Cancer Center Medical Visit Variable Total No. % OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI) Note: results adjusted for age, sex, and race; percentages are based upon the total with available data for each variable. OR = odds ratio; CI = confidence intervals; RT = radiation therapy. * High-risk therapy: treatment with any of the following: chest-mantle radiation, anthracycline >300 mg/m2, bleomycin, etoposide, or ifosfamide. Chest-mantle RT No 6,013 12.5 1.00 Referent 30.6 1.00 Referent 59.4 1.00 Referent 79.7 1.00 Referent Yes 1,802 8.2 0.68 0.57–0.83 24.6 0.64 0.56–0.73 47.9 0.60 0.53–0.67 70.3 0.50 0.43–0.57 Anthracycline <300 mg/m2 6,459 11.1 1.00 Referent 29.4 1.00 Referent 53.6 1.00 Referent 72.6 1.00 Referent ≥300 mg/m2 1,508 10.7 0.88 0.73–1.06z 27.4 0.96 0.84–1.11 51.7 0.77 0.68–0.88 69.8 0.65 0.56–0.75 Bleomycin No 7,642 12.2 1.00 Referent 29.4 1.00 Referent 58.4 1.00 Referent 81.5 1.00 Referent Yes 581 7.8 0.58 0.42–0.81 25.7 0.80 0.65–0.99 40.8 0.48 0.40–0.58 67.0 0.47 0.38–0.57 High-risk therapy* No 4,304 13.2 1.00 Referent 31.3 1.00 Referent 61.9 1.00 Referent 83.1 1.00 Referent Yes 3,449 10.0 0.70 0.60–0.82 26.4 0.74 0.66–0.83 50.7 0.58 0.53–0.65 71.1 0.45 0.39–0.50
In this issue
Jump to section
Related Articles
Cited By...
- Integrating primary care and childhood cancer survivorship care: a scoping review protocol
- Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study
- Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study
- Preventive Health in Cancer Survivors: What Should We Be Recommending?
- Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma
- Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
- Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030
- Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study
- Impact of Tailored Education on Awareness of Personal Risk for Therapy-Related Complications Among Childhood Cancer Survivors
- Enhancing Health Care of Survivors of Childhood Cancer With Tailored Education
- Statewide Longitudinal Hospital Use and Charges for Pediatric and Adolescent Patients With Cancer
- Age-Dependent Changes in Health Status in the Childhood Cancer Survivor Cohort
- Risk of Hospitalization for Survivors of Childhood and Adolescent Cancer
- What the Affordable Care Act Means for Survivors of Pediatric Cancer
- Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions: A Scientific Statement From the American Heart Association
- Adolescent and Young Adult Oncology
- Psychosocial Care of Adolescent and Young Adult Patients With Cancer and Survivors
- Health Care Use of Long-Term Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study
- Impact of Survivorship-Based Research on Defining Clinical Care Guidelines
- Improving the transition between paediatric and adult healthcare: a systematic review
- Transition of Care for Young Adult Survivors of Childhood and Adolescent Cancer: Rationale and Approaches
- Psychological Outcomes and Health Beliefs in Adolescent and Young Adult Survivors of Childhood Cancer and Controls
- Physician Preferences and Knowledge Gaps Regarding the Care of Childhood Cancer Survivors: A Mailed Survey of Pediatric Oncologists
- Health Behaviors, Medical Care, and Interventions to Promote Healthy Living in the Childhood Cancer Survivor Study Cohort
- The Childhood Cancer Survivor Study: A National Cancer Institute-Supported Resource for Outcome and Intervention Research
- A Framework for Assessment in Oncology Rehabilitation
- Cancer Survivorship: A Pediatric Perspective
- Longitudinal Changes in Obesity and Body Mass Index Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study
- Health Care Utilization by Adult Long-term Survivors of Hematopoietic Cell Transplant: Report from the Bone Marrow Transplant Survivor Study
- Curing Childhood Cancer Is Not Enough
- Health Insurance Coverage in Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
- Minority Adult Survivors of Childhood Cancer: A Comparison of Long-Term Outcomes, Health Care Utilization, and Health-Related Behaviors From the Childhood Cancer Survivor Study
- Cancer Survivorship--Pediatric Issues
- How to Use the Annals Online Discussion
- On TRACK
- In this Issue: Multimethod Research